Probable drug-induced liver injury with kedaling tablets : A case report
and systematic literature review
Abstract
Kedaling tablets is an extract of with Corydalis yanhusuo W.T. Wang and
used to coronary heart disease, angina pectoris, myocardial infarction
with no previously well documented hepatotoxicity. We report the first
case of kedaling tablets-related drug-induced liver injury (DILI), which
highlights the need for clinician awareness regarding potential
hepatotoxicity of kedaling tablets, particularly among patients with
pre-existing liver disease.